Hostname: page-component-54dcc4c588-2bdfx Total loading time: 0 Render date: 2025-10-01T10:00:32.726Z Has data issue: false hasContentIssue false

The concordance between the Montreal cognitive assessment and the repeatable battery for the assessment of neuropsychological status as a cognitive screening tool in a south African community sample

Published online by Cambridge University Press:  08 August 2025

Sharain Suliman*
Affiliation:
Department of Psychiatry, Faculty of Medicine and Health Sciences, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa South African Medical Research Council Unit on the Genomics of Brain Disorders, Department of Psychiatry, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa
Erine Bröcker
Affiliation:
Department of Psychiatry, Faculty of Medicine and Health Sciences, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa South African Medical Research Council Unit on the Genomics of Brain Disorders, Department of Psychiatry, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa
Natalie Beath
Affiliation:
Department of Psychiatry, Faculty of Medicine and Health Sciences, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa
Leigh L. Van den Heuvel
Affiliation:
Department of Psychiatry, Faculty of Medicine and Health Sciences, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa South African Medical Research Council Unit on the Genomics of Brain Disorders, Department of Psychiatry, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa
Laila Asmal
Affiliation:
Department of Psychiatry, Faculty of Medicine and Health Sciences, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa South African Medical Research Council Unit on the Genomics of Brain Disorders, Department of Psychiatry, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa
Sanja Kilian
Affiliation:
Department of Psychiatry, Faculty of Medicine and Health Sciences, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa
Robin Emsley
Affiliation:
Department of Psychiatry, Faculty of Medicine and Health Sciences, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa
Jonatha Carr
Affiliation:
South African Medical Research Council Unit on the Genomics of Brain Disorders, Department of Psychiatry, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa Division of Neurology, Department of Medicine, Faculty of Medicine and Health Sciences, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa
Soraya Seedat
Affiliation:
Department of Psychiatry, Faculty of Medicine and Health Sciences, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa South African Medical Research Council Unit on the Genomics of Brain Disorders, Department of Psychiatry, https://ror.org/05bk57929Stellenbosch University, Cape Town, South Africa
*
Corresponding author: Sharain Suliman; Email: sharain@sun.ac.za
Rights & Permissions [Opens in a new window]

Abstract

We aimed to compare the concordance between the Montreal Cognitive Assessment (MoCA) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), as cognitive screening tools to detect mild cognitive impairment (MCI) in a South African adult community sample (N = 370).

The MoCA showed acceptable internal consistency, agreement with the RBANS and good criterion-related validity. The MoCA demonstrated fair performance, compared to the RBANS, for predicting MCI, with AUCs of 0.711 (English) and 0782 (Afrikaans). Using the recommended cut-off score of 26/30, the MoCA showed high sensitivity but low specificity. Sensitivity and specificity were optimal when the cut-off scores were lowered to 25/30 (English) and 24/30 (Afrikaans). MoCA scores were significantly associated with language, sex, age and education.

While these findings demonstrate applicability of the MoCA in screening for and identifying mild cognitive difficulty in this population, our findings suggest that modifications are needed to improve differentiating between normal aging and MCI. Until a culturally adapted version of the MoCA is developed and validated for this population we suggest lowering the cut-off score to 25/30 (English) and 24/30 (Afrikaans) to reduce false positive NCD diagnoses. Demographic factors (age, sex, language and education) also need to be considered.

Topics structure

Subtopic(s)

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NC
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial licence (http://creativecommons.org/licenses/by-nc/4.0), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original article is properly cited. The written permission of Cambridge University Press must be obtained prior to any commercial use.
Copyright
© The Author(s), 2025. Published by Cambridge University Press

Impact statement

  • - The MoCA appears to be a useful tool to screen for cognitive difficulties in this South African population.

  • - That said, some cultural adaptation is needed, and demographics factors such as age, sex, language and education should be considered, to improve the ability of the MoCA to identify MCI.

  • - Until a culturally adapted version of the MoCA has been developed for this population, we suggest that a cut-off score of 25/30 is used for the English version and 23 or 24/30 is used for the Afrikaans version, to reduce incorrectly identifying cognitive difficulties.

Background

Routine screening and monitoring of cognitive function is critical to optimal clinical management of patients across disciplines (Dolansky et al., Reference Dolansky, Hawkins, Schaefer, Sattar, Gunstad, Redle, Josephson, Moore and Hughes2016; Cho et al., Reference Cho, Shin, Chang, Lee, Jeong, Kim, Yun and Son2018; Hagi et al., Reference Hagi, Nosaka, Dickinson, Lindenmayer, Lee, Friedman, Boyer, Han, Abdul-Rashid and Correll2021; Zhou et al., Reference Zhou, Yu, Luo, Xie, Wang and Wan2021). Undetected cognitive impairment can impair treatment outcomes such as therapeutic receptiveness (e.g., ability to engage in psychotherapeutic processes or pharmacological treatment adherence) (Knight et al., Reference Knight, Mills and Baune2019; Sachs et al., Reference Sachs, Berg, Jagsch, Lenz and Erfurth2020; Wu et al., Reference Wu, Yu, Li, Chen and Wang2023). Additionally, if left undetected and therefore untreated, individuals presenting with cognitive decline can progressively deteriorate, significantly impacting their activities of daily living (ADLs) and resulting in an overall poorer quality of life (Hill et al., Reference Hill, McDermott, Mogle, Munoz, Depasquale, Wion and Whitaker2017).

Depending on the severity of cognitive impairment and the degree of functional impairment present, a diagnosis of a mild or major neurocognitive disorder (NCD) may be warranted (American Psychiatric Association [APA], 2013). While both mild and major NCD indicate a decline from premorbid cognitive functioning, major NCD, also known as dementia, requires significant impairment in one or more of the principal cognitive domains (complex attention, executive function, learning and memory, language, visuospatial and social cognition). These impairments represent a decline from a previous level of functioning of sufficient severity to interfere with ADLs (APA, 2013). Conditions such as traumatic brain injury (TBI) or advanced human immunodeficiency virus (HIV) can result in NCDs (APA, 2013). Other etiologies of NCDs include Alzheimer’s disease, vascular pathology, Lewy body dementia and frontotemporal lobar degeneration. Ageing remains the most significant risk factor for NCDs, and considering the growing elderly population globally and in South Africa, the prevalence of age-related diseases, such as NCDs, is likely to rise (Martin Prince et al., Reference Martin Prince, Wimo, Guerchet, Gemma-Claire Ali, Y-T, Prina, Yee Chan and Xia2015; World Health Organization (WHO), 2024). Once diagnosed, most major NCDs are usually irreversible, relatively treatment-resistant, and greater psychosocial and healthcare demands need to be met in order for management to be effective (Rasmussen and Langerman, Reference Rasmussen and Langerman2019). Due to resource constraints faced by many low to middle-income countries (LMICs), such as South Africa, effective management is challenging (Docrat et al., Reference Docrat, Besada, Cleary, Daviaud and Lund2019; Shisana et al., Reference Shisana, Stein, Zungu and Wolvaardt2024).

Compared to major NCD, mild NCD, also known as mild cognitive impairment (MCI), entails more subtle and modest concerns about cognitive decline. This decline typically presents without significant interference with ADLs, such that the person can still function independently (APA, 2013). Therefore, mild NCD represents an intermediate state between normal age-related cognitive decline and major NCDs, representing a critical intervention period (Salzman et al., Reference Salzman, Sarquis-Adamson, Son, Montero-Odasso and Fraser2022) While mild NCD is a risk factor itself for developing a major NCD, such as Alzheimer’s dementia there are other modifiable factors which increase the risk of the progression to a major NCD (Sabbagh et al., Reference Sabbagh, Boada, Borson, Chilukuri, Dubois, Ingram, Iwata, Porsteinsson, Possin, Rabinovici, Vellas, Chao, Vergallo and Hampel2020; Nezhadmoghadam et al., Reference Nezhadmoghadam, Martinez-Torteya, Treviño, Martínez, Santos and Tamez-Peña2021; Wolfova et al., Reference Wolfova, Kucera and Cermakova2021). Some of these modifiable factors include cardiometabolic (Lu et al., Reference Lu, Fülöp, Gwee, Lee, Lim, Chong, Yap, Yap, Pan and Ng2022), treatment adverse effects (Breijyeh and Karaman, Reference Breijyeh and Karaman2020; Franzoi et al., Reference Franzoi, Agostinetto, Perachino, Del Mastro, de Azambuja, Vaz-Luis, Partridge and Lambertini2021), vitamin deficiencies such as vitamin B12 or folate (Zhang et al., Reference Zhang, Luo, Yuan and Ding2020), psychiatric conditions such as severe depression (Varghese et al., Reference Varghese, Frey, Schneider, Kapczinski and de Azevedo Cardoso2022) and suboptimally treated infections such as HIV and syphilis (Hernandez-Ruiz et al., Reference Hernandez-Ruiz, Letenneur, Fülöp, Helmer, Roubaud-Baudron, Avila-Funes and Amieva2022). These may be addressed by dietary and lifestyle changes or appropriate pharmacological treatment, resulting in improved cognition, greater quality of life and notably decreased psychosocial and healthcare resource needs (Zhang et al., Reference Zhang, Xu, Zhang, Wang, Ou, Qu, Shen, Chen, Wu, Zhao, Zhang, Sun, Dong, Tan, Feng, Zhang, Evangelou, Smith and Yu2022). This is particularly relevant to South Africa, given the high prevalence of these potentially modifiable risk factors in South Africa accompanied by significant resource constraints (Docrat et al., Reference Docrat, Besada, Cleary, Daviaud and Lund2019; Alkhatib et al., Reference Alkhatib, Nnyanzi, Mujuni, Amanya and Ibingira2021; Greene et al., Reference Greene, Yangchen, Lehner, Sullivan, Pato, McIntosh, Walters, Gouveia, Msefula, Fumo, Sheikh, Stockton, Wainberg and Weissman2021; Monyeki et al., Reference Monyeki, Mkhatshwa, Thulare, Kemper, Kengne and Moselakgomo2023 ; Cassambai et al., Reference Cassambai, Tetteh, Highton, Kunutsor, Darko, Jeffers, Ikhile, Agot, Olenja, Njoroge, Jessen, Abdala, Senior, Coleman, Khunti, Godia, Alfred, Lamptey, Buabeng, Damasceno and Seidu2024 ; Malan et al., Reference Malan, Zandberg, Visser, Wicks, Kruger and Faber2024). Considering this high prevalence of modifiable risk factors in South Africa, early detection of cognitive decline is a fundamental first step in initiating early intervention, specifically at the community-based level within the public healthcare (PHC) system (Sabbagh et al., Reference Sabbagh, Boada, Borson, Chilukuri, Dubois, Ingram, Iwata, Porsteinsson, Possin, Rabinovici, Vellas, Chao, Vergallo and Hampel2020). However, owing to the subtle changes in mild NCD and resource constraints, it can remain undetected. This necessitates identifying available, suitable, efficient and reliable cognitive screening tools that are sensitive, appropriate, and easily administered (de Villiers, Reference de Villiers2021; Shisana et al., Reference Shisana, Stein, Zungu and Wolvaardt2024).

Several cognitive bedside administered screening tools are available, each with advantages and limitations (Zhuang et al., Reference Zhuang, Yang and Gao2021). The Montreal Cognitive Assessment (MoCA), developed and validated by Nasreddine et al. (Reference Nasreddine, Phillips, Bédirian, Charbonneau, Whitehead, Collin, Cummings and Chertkow2005), is a freely available one-page, 30-item test typically administered within 10–15 min (www.mocatest.org). While freely available, the MoCA developers encourage virtual training and certification to ensure correct administration. The MoCA evaluates eight cognitive domains: executive functions, visuospatial abilities, short-term and delayed verbal memory, language, attention, concentration, working memory and temporal and spatial orientation. This original MoCA paper version, the MoCA Full, was validated in an English/French-speaking older Canadian sample of adults with normal cognition, mild NCD and Alzheimer’s disease. Using a cut-off score of ≥ 26/30, with an education correction of one point for individuals with ≤ 12 years of education, the sensitivity of the MoCA for identifying mild NCD was 90% and the specificity was 87% (Nasreddine et al., Reference Nasreddine, Phillips, Bédirian, Charbonneau, Whitehead, Collin, Cummings and Chertkow2005). The original face-to-face administered MoCA Full is now available in over 100 languages, including Afrikaans, isiXhosa, and Zulu, and has advanced in terms of administration modes (e.g. electronic or audio-visual version); sensory adaptation (e.g. MoCA-Blind), and multiple versions to monitor cognitive changes.

Since its release, several countries have evaluated the reliability and validity of the MoCA Full (Freitas et al., Reference Freitas, Simões, Alves and Santana2011; Narazaki et al., Reference Narazaki, Nofuji, Honda, Matsuo, Yonemoto and Kumagai2012; Yu et al., Reference Yu, Li and Huang2012; Memõria et al., Reference Memõria, Yassuda, Nakano and Forlenza2013; Kirkbride et al., Reference Kirkbride, Ferreira-Correia and Sibandze2022; Geller and Slicer, Reference Geller and Slicer2024; Lau et al., Reference Lau, Lin, Lin, Li, Yao, Lin and Wu2024). While the MoCA has shown good reliability and validity in screening for cognitive impairment in some settings limitations and item level and cut-off score modifications have been suggested (Freitas et al., Reference Freitas, Simões, Alves and Santana2011; Narazaki et al., Reference Narazaki, Nofuji, Honda, Matsuo, Yonemoto and Kumagai2012; Yu et al., Reference Yu, Li and Huang2012; Memõria et al., Reference Memõria, Yassuda, Nakano and Forlenza2013). Item-level changes were motivated by cultural sensitivity, recommending replacing foreign animals with more familiar indigenous animals (language domain), and replacing words in the delayed recall test with words from participants’ cultural background (e.g., velvet with silk in the case of the Chinese population) (Freitas et al., Reference Freitas, Simões, Alves and Santana2011; Narazaki et al., Reference Narazaki, Nofuji, Honda, Matsuo, Yonemoto and Kumagai2012; Yu et al., Reference Yu, Li and Huang2012; Memõria et al., Reference Memõria, Yassuda, Nakano and Forlenza2013). Accompanied by cut-off score modification, the reliability and validity of the MoCA in detecting mild NCD is supported in some African countries (Daniel et al., Reference Daniel, Agenagnew, Workicho and Abera2022), including South Africa (Rademeyer and Joubert, Reference Rademeyer and Joubert2016; Thungana, Reference Thungana2022; Van Wijk et al., Reference Van Wijk, Meintjes, Muller, Van Wijk, Wijk, Meintjes and Muller2024). At the same time, other South African-based researchers have questioned the reliability and validity of the test in our setting? (Robbins et al., Reference Robbins, Joska, Thomas, Stein, Linda, Mellins and Remien2013 ; Hakkers et al., Reference Hakkers, Beunders, Ensing, Barth, Boelema, Devillé, Tempelman, Coutinho, Hoepelman, Arends and van Zandvoort2018 ; Kirkbride et al., Reference Kirkbride, Ferreira-Correia and Sibandze2022).

Another cognitive screening tool is the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), which is increasingly used and has been extensively researched (Randolph et al., Reference Randolph, Tierney, Mohr and Chase1998; Pandya, Reference Pandya2020; Suliman et al., Reference Suliman, van den Heuvel, Kilian, Bröcker, Asmal, Emsley and Seedat2021 ; Ikanga et al., Reference Ikanga, Patrick, Schwinne, Patel, Epenge, Gikelekele, Tshengele, Kavugho, Mampunza, Yarasheski, Teunissen, Stringer, Levey, Rojas, Chan, Lario Lago, Kramer, Boxer, Jeromin, Alonso and Spencer2024). Originally developed as a brief neuropsychological screening battery for NCDs in older adults, the RBANS has normative data for ages 20–89 and requires approximately 20–30 min administration time (Randolph et al., Reference Randolph, Tierney, Mohr and Chase1998). Similar to the MoCA, the RBANS has multiple versions (Form A–D), making it helpful in monitoring cognitive changes over time (Randolph et al., Reference Randolph, Tierney, Mohr and Chase1998). However, relative to the MoCA, the RBANS offers a more in-depth assessment which may improve reliability and validly in detecting cognitive impairment (Randolph et al., Reference Randolph, Tierney, Mohr and Chase1998; Paul et al., Reference Paul, Lane, Tate, Heaps, Romo, Akbudak, Niehoff and Conturo2011; Shaughnessy et al., Reference Shaughnessy, Rucker and Sanchez2019). The RBANS comprises twelve sub-tests combined to form five index scores and a total score. These five indexes are immediate verbal memory, visuospatial/constructional, language, attention and delayed memory (including verbal and visuospatial). The RBANS index scores are converted to descriptive performance classifications: exceptionally high, above average, high average, average, low average, below average and extremely low (Guilmette et al., Reference Guilmette, Sweet, Hebben, Koltai, Mahone, Spiegler, Stucky and Westerveld2020). Since the publication of the RBANS in 1998, multiple studies have evaluated the reliability, validity, and clinical utility of the tool (De La Torre et al., Reference De La Torre, Suárez-Llorens, Caballero, Ramallo, Randolph, Lleó, Sala and Sánchez2014; Thaler et al., Reference Thaler, Hill, Duff, Mold and Scott2015). Initially available in English and Spanish, the RBANS has been translated into over 40 languages and demonstrated good sensitivity and specificity in identifying patients with Alzheimer’s disease and mild NCD (Karantzoulis et al., Reference Karantzoulis, Novitski, Gold and Randolph2013). Although initially developed for the evaluation of NCD due to Alzheimer’s disease, the RBANS has been used to assess a wide variety of clinical populations, including HIV-associated NCD (Bucher et al., Reference Bucher, Leonhard and Michael Bradley2022), TBI (Arch and Ferraro, Reference Arch and Ferraro2021), depression (Faust et al., Reference Faust, Nelson, Sarapas and Pliskin2017), and Parkinson’s disease (Yang et al., Reference Yang, Garrett-Mayer, Schneider, Gollomp and Tilley2009) among others (Shaughnessy et al., Reference Shaughnessy, Rucker and Sanchez2019). A study that assessed for cross-cultural systematic differences on the RBANS reported no systematic cultural/linguistic bias that would require adjustments to the translations, which, given some of the raised concerns about the MoCA, supports the RBANS as an appealing option (Weber et al., Reference Weber, Randolph and Negash2019).

Considering significant resource constraints and conflicting findings about the reliability and validity of the MoCA in our setting, the purpose of the current study was to evaluate the concordance between the MoCA (Version 7.1) and the RBANS (Version A) as cognitive screening tools to detect mild NCD in a South African adult community sample. Results of this study can inform whether a bedside test, such as the MoCA, can be used in place of longer neurocognitive batteries in our setting. Second, we aimed to contribute to the growing body of literature on the MoCA in South Africa by generating data to further inform the optimal cut-off score to detect cognitive impairment in our sample and setting. We also aimed to evaluate whether demographic factors such as sex and age influence performance and should be considered when interpreting MoCA performance in our setting. This can inform ‘a best approach’ when using and interpreting these available tools in our setting and whether further linguistic and cultural adaptation is needed. To the best of our knowledge, this is the first study to directly evaluate and compare the MoCA and RBANS in a South African setting.

Methods

Study design and setting

The current study was a cross-sectional observational study nested in the ’Understanding the Shared Roots of Neuropsychiatric Disorders (NPD) and Modifiable Risk Factors for Cardiovascular Disease’ (Shared Roots) project. The Shared Roots project was conducted in Cape Town, Western Cape, South Africa (Health Research Ethics Committee [HREC] at Stellenbosch University: N13/08/115). Participants were recruited through purposive sampling using community newspaper advertisements and flyers and were drawn from the dominant ethnic group (mixed ancestry) in this geographical region. The project aimed to investigate contributing factors to comorbidity in neuropsychiatric disorders (NPDs) and metabolic syndrome (MetS). Its aim was investigated in three NPD cohorts: posttraumatic stress disorder (PTSD), schizophrenia, and Parkinson’s disease (PD). The Shared Roots project was a cross-sectional matched case–control study (van den Heuvel et al., Reference van den Heuvel, Stalder, du Plessis, Suliman, Kirschbaum and Seedat2020), and the current study was conducted in the control cohort.

Participants

Shared Roots’ participants were adults (≥ 18 years old) who could read and understand the written informed consent forms in English or Afrikaans, which are the main languages spoken within the Western Cape as well as within the mixed ancestry population (Savedra et al., Reference Savedra, Rosenberg, Macedo and Macedo2021). Based on a clinical history and diagnostic interview, participants were excluded from the control cohort if they (i) had a neurological disorder, (ii) had major current psychiatric disorders including current psychiatric medication use, (iii) had a major medical illness (e.g. epilepsy, stroke, cancer or chronic infections such HIV), (iv) were known with intellectual disability or significant head injury resulting in loss of consciousness, or (v) had a diagnosis of a major neurocognitive disorder. As a result, the sample consisted of generally healthy adults without serious psychiatric or medical morbidity, which might affect cognitive performance.

Procedures

Shared Roots’ participants were assessed for the presence of any psychiatric disorder with a clinician-administered diagnostic interview— the MINI International Neuropsychiatric Interview (Sheehan et al., Reference Sheehan, Lecrubier, Sheehan, Amorim, Janavas, Weiller, Hergueta and Dunbar1998). Participants also underwent metabolic syndrome screening, neurocognitive tests, blood sampling (e.g. for genomic analyses) and neuroimaging assessments. Study procedures, including the MoCA and RBANS administration, were conducted in English/Afrikaans based on participant preference. The English and Afrikaans MoCA versions were obtained from the website, https://mocacognition.com/, and the English and Afrikaans RBANS source documents, adapted for the South African population with minor changes to the List Recall and Story Memory subtest wording, from the developer. The study team included a psychiatrist, a physician experienced in psychiatry, two psychologists and research nurses. Participants were reimbursed for their travel costs.

Statistical analysis

Statistical analyses were undertaken using Statistica (version 13) and SPSS (version 29). All tests were 2-sided, and statistical significance was set at p < 0.05. Descriptive statistics were computed for MoCA total and domain scores. Criterion validity for global cognition and domain scores between the MoCA and RBANS was assessed using Pearson’s correlation tests. Pearson’s correlation coefficients were also used to determine associations between age and education, and MoCA scores. ANOVAs were used to establish the association between MoCA scores and categorical variables (e.g., sex). The internal consistency of the MoCA was derived using Cronbach’s alpha. Regression analysis was used to create age and education-adjusted z-scores for both the MoCA and RBANS, which were converted to standard scores.

The MoCA consists of 28 items, 27 of which are scored out of 1 and one item (serial 7), which is scored out of 3. Firstly, the serial 7 s item scores were transformed in SPSS to a score out of 1 by dividing the existing scores by 3, thus allowing us to compare all the scores out of 1. Second, a composite mean score was created for all the items (scored out of 1) combined; the mean for this composite score was 0.805 (SD 0.098) for the English and 0.769 (SD 0.109) for the Afrikaans samples, respectively. Items that participants performed poorly in were considered items with a score of more than 2 SD below the mean for the composite score (i.e. less than 0.61 for the English sample and less than 0.55 for the Afrikaans sample).

A Bland–Altman plot was derived to compare the agreement between the MoCA and RBANS and to assess for bias. The Bland Altman plot used raw scores and is a plot on the X axis of the mean of the 2 measures (RBANS/MoCA) taken for each participant, with the Y axis representing the arithmetical difference between the two measures.

Receiver operator characteristics (ROC) analysis was undertaken to assess whether MoCA total scores predicted mild NCD according to the RBANS. Mild NCD was defined as one standard deviation (1SD) below the mean of the standardized score (a score of 85 or less) (Duff et al., Reference Duff, Hobson, Beglinger and O’Bryant2010). We assessed the sensitivity and specificity of the two scales by using recommended cut-off scores of ≤ 26/30 for the MoCA) (Nasreddine et al., Reference Nasreddine, Phillips, Bédirian, Charbonneau, Whitehead, Collin, Cummings and Chertkow2005) and ≤ 85 (1SD below the mean) for the RBANS (Duff et al., Reference Duff, Hobson, Beglinger and O’Bryant2010).

We report cut-off scores for optimal sensitivity and specificity based on the data. Area under the curve (AUC) was used to compare the diagnostic performance between the MoCA and the RBANS. Finally, multiple regression analysis was performed with the MoCA score as the dependent variable and age, sex, and years of education as the independent variables.

Results

Sample characteristics

The final sample (N = 370) was primarily female (70.8%), with a mean age of 45.96 years (SD:15.07; range = 18–81 years). The majority were Afrikaans first language speaking (73.8%) and had completed secondary school (79.5%) with a mean of 11.06 ± 2.72 years of education (education range = 4–25). When stratified by language, Afrikaans participants were significantly older (p ≤ 0.001) and had lower education levels (p ≤ 0.001) (see Table 1).

Table 1. Participant characteristics stratified by language

Note: In view of missing data, percentages may not add up to 100%.

MoCA performance

The MoCA showed acceptable internal consistency in both the English and Afrikaans versions (Cronbach alpha = 0.582 and 0.694, respectively). The variables ’orientation to place’ and ’orientation to city’, however, showed zero variance and, as a result, were removed from the analysis.

Age was significantly correlated with the MoCA total score, with older participants performing worse (r = −0.203, p ≤ 0.001). Female participants also performed worse (F = 18.37, p ≤ 0.001), as well as participants with fewer years of education (r = 0.326, p ≤ 0.001). Gender was associated with education with female participants having lower education levels (F(1) = 16.6, p ≤ 0.001. Age was moderately correlated with total years of education (r = −0.434; p ≤ 0.001).

Below-average (2SD below the mean) scores were observed on a number of MoCA items: ‘Alternate Trail Making’, ’Cube copying’, Language: Sentence 2 Repetition ’Verbal fluency’, ’Abstraction: watch-ruler’, ’Recall: face, church, daisy’. These can be seen in Table 2.

Table 2. MoCA item scores

Note: For above items minimum was 0 and maximum was 1.

All of the 28 MoCA items are scored out of 1 except for Serial 7 which is scored out of 3. Serial 7 results were divided by 3 to produce a score out of 1 that other items could be compared to.

A composite score for all the items was then created; the mean for this composite score was 0.805 (SD 0.098) for the English and 0.769 (SD 0.109) for the Afrikaans samples respectively. Items that participants performed poorly in were considered items with a score of more than 2SD below the mean for the composite score (i.e., less than 0.61 for the English sample and 0.55 for the Afrikaans sample).

Concordance between MoCA and RBANS in evaluating mild NCD

There was a moderate correlation between MoCA and RBANS total scores (r = 0.615; p ≤ 0.001; Eng: r = 0.510, p ≤ 0.001; Afr: r = 0.639, p ≤ 0.001), indicating acceptable criterion-related validity. Correlations were also run on MoCA and RBANS domain scores with MoCA visuo-executive and RBANS visuospatial showing a moderate correlation (r = 0.511, p ≤ 0.001; Eng: r = 0.408; p ≤ 0.001; Afr: r = 0.559, p ≤ 0.001), RBANS delayed memory and MoCA delayed recall a moderate correlation (r = 0.431, p ≤ 0.001; Eng: r = 0.416, p ≤ 0.001; Afr: r = 0.421, p ≤ 0.001) and MoCA and RBANS attention (r = 0.281, p = p ≤ 0.001; Eng: r = 0.312, p ≤ 0.001; Afr: r = 0.269, p ≤ 0.001) and MoCA and RBANS language (r = 0.235, p ≤ 0.001; Eng: r = 0.282; p = 0.04; Afr: r = 0.223, p ≤ 0.001) showing weak correlations.

The Bland–Altman Plot (see Figures 1 and 2 ) indicated good agreement between the MoCA and RBANS and no proportional bias between the two tests. Random scatter around the zero-difference lines and the correlation coefficient between the differences and the averages were not statistically significant (Eng: t = −0.902, p = 0.369; Afr: t = −0.056, p = 0.956).

Figure 1. (a) Bland–Altman Plot – English. (b) Bland–Altman Plot – Afrikaans.

Figure 2. (a) ROC Curve: MoCA compared to RBANS – English. (b) ROC Curve: MoCA compared to RBANS – Afrikaans.

The mean score on the MoCA was 23.41 (SD = 3.23, range 8–30) and the mean raw score on the RBANS 200.37 (SD = 28.17, range 73–289). Previous studies have shown good sensitivity and specificity for RBANS scaled scores in predicting mild NCD at 1SD below a mean of 100 (i.e., at a score of below 85) (Duff et al., Reference Duff, Hobson, Beglinger and O’Bryant2010). As such, we transformed the raw scores to scaled scores and used this as our cut-off score for mild NCD. One hundred-and-twenty participants (32.4%) scored both ≥ 85 on the RBANS and ≥ 26 on the MoCA, and 45 (12.2%) participants scored below both the MoCA and RBANS cut-off points. One hundred and ninety-six participants (53%) scored ≥ 85 on the RBANS and < 26 on the MoCA. Seven participants (2%) scored < 85 on the RBANS and ≥ 26 on the MoCA.

The ROC curves (see Figures 2a,b) demonstrated that the performance of the MoCA for predicting cognitive impairment compared to the RBANS was fair. The AUC for the English sample was 0.711 (95%CI: 0.547, 0.876; p = 0.022). For the Afrikaans sample, the AUC was 0.782 (95%CI: 0.703, 0.861; p = 0.001).

Using the recommended cut-off score of 26/30, the MoCA showed high sensitivity (Eng: 81.8%; Afr: 87.8%) but low specificity (Eng: 43.6%; Afr: 35.0%). In the present study, the cut-off score for optimal sensitivity and specificity to detect mild NCD was 25 for the English sample. At this cut-off, the sensitivity remained at 81.1% and the specificity increased to 57.4%. The optimal cut-off for the Afrikaans sample was between 23 and 24. The sensitivity and specificity were 68.3% and 75.9%%, respectively, for a MoCA cut-off of 23 and 78.0% and 64.1%, for a MoCA cut-off of 24 (see Table 3).

Table 3. Summary of different MoCA cut-off scores predicting MCI on the RBANS

Discussion

We set out to determine the concordance between two cognitive screening tools – the MoCA and the RBANS – and to identify the optimal cut-off score for the MoCA to detect mild NCD in our sample. Good concordance would suggest that the briefer MoCA can be substituted for longer neurocognitive assessments such as the RBANS, saving time and resources. We also hoped to evaluate whether demographic factors influenced performance in our sample. This will assist in identifying whether adapted norms are required. Additionally, we hoped to contribute to the growing body of literature on the use of the MoCA in South Africa to further inform a ‘best approach’ when using and interpreting available tools in the linguistically, culturally, educationally and economically diverse South African setting.

We first evaluated psychometric properties of the MoCA in our sample and found acceptable internal consistency and good criterion-related validity. This aligns with a South African study, and the few African studies that have measured internal consistency in the MoCA (Masika et al., Reference Masika, Yu and Li2021 ; Kirkbride et al., Reference Kirkbride, Ferreira-Correia and Sibandze2022 ; Daniel et al., Reference Daniel, Agenagnew, Workicho and Abera2022). It differs, however, from the only other published South African study, which reported low reliability (Van Wijk et al., Reference Van Wijk, Meintjes, Muller, Van Wijk, Wijk, Meintjes and Muller2024). This may be since the Van Wijk study utilized a different measure of internal consistency to the other studies. Given the dearth of reliability and validity data on the MoCA for the South African population, these are important findings.

Overall, there was concordance between the MoCA and the RBANS, suggesting fair reliability of the MoCA in identifying mild NCD in our sample, albeit using lower cut-off scores for detection (≤ 25/30 when using the English version and ≤ 23 or 24/30 when using the Afrikaans version). Thus, our findings support previous South African-based research of cut-off score modification to improve MoCA reliability and validity in our context (Rademeyer and Joubert, Reference Rademeyer and Joubert2016; Thungana, Reference Thungana2022; Van Wijk et al., Reference Van Wijk, Meintjes, Muller, Van Wijk, Wijk, Meintjes and Muller2024). Similar to previous research, analysis of MoCA domain and item-level scores suggests that some items may need modification (Freitas et al., Reference Freitas, Simões, Alves and Santana2011; Narazaki et al., Reference Narazaki, Nofuji, Honda, Matsuo, Yonemoto and Kumagai2012; Yu et al., Reference Yu, Li and Huang2012 ; Memõria et al., Reference Memõria, Yassuda, Nakano and Forlenza2013). MoCA language and recall domains showed a weak correlation with corresponding RBANS domains. These findings could potentially be accounted for by cultural variations in the use of language between our sample and the original cultural/language groups which the MoCA was validated. Since the sample was largely Afrikaans-speaking, our findings suggest that further adaptations may be warranted to the currently available Afrikaans translation of the MoCA as well as the original English version.

Regarding individual items, participants scored significantly below average on abstraction (watch-ruler), cube copying and alternate trail making, as well as verbal fluency and recall. The relatively lower level of education (mean education years = 11.05 ± 2.72) of our sample compared with the original validation sample, and the ‘outlier’ items above (which may reflect cultural differences), may, to some extent, account for the inconsistent findings. A study that investigated the discriminant validity of the MoCA in South African samples with HIV and psychiatric/neurocognitive disorders compared to controls found similarly low scores in the entire sample, and a mean of 22 in the healthy control group (Kirkbride et al., Reference Kirkbride, Ferreira-Correia and Sibandze2022). It is possible that linguistic tests that are more culturally appropriate and visuospatial and abstraction items that are simpler and more in line with the average level of education of the South African population would fare better at detecting cognitive difficulties.

The MoCA had good sensitivity in detecting mild NCD at the recommended cut-off score of ≥ 26/30. However, at this cut-off score, the specificity was very low, making it likely that many participants would receive a false positive diagnosis of mild NCD. The optimal MoCA cut-off scores for identifying mild NCD were ≤ 25/30 for the English sample and ≤ 23 or 24/30 for the Afrikaans sample. At these scores, sensitivity decreased while specificity increased. Considering these findings, we would suggest lowering the MoCA cut-off score in this population to ≤ 25/30 and ≤ 23 or 24/30 for the English and Afrikaans samples, respectively. A number of other researchers, including those in other African settings, have similarly suggested that the original cut-off score of 26/30 be reduced, in order to reduce misclassification of individuals from different cultures and contexts (Conti et al., Reference Conti, Bonazzi, Laiacona, Masina and Coralli2015; Wong et al., Reference Wong, Law, Liu, Wang, Lo, Lau, Wong and Mok2015 ; Pinto et al., Reference Pinto, Machado, Bulgacov, Rodrigues-Júnior, Costa, Ximenes and Sougey2019 ; Masika et al., Reference Masika, Yu and Li2021 ; Daniel et al., Reference Daniel, Agenagnew, Workicho and Abera2022).

Demographic variables that demonstrated a significant negative correlation with MoCA scores included age, while years of education showed a positive correlation. This is consistent with other literature on the MoCA (Malek-Ahmadi et al., Reference Malek-Ahmadi, Powell, Belden, Oconnor, Evans, Coon and Nieri2015; Pinto et al., Reference Pinto, Machado, Bulgacov, Rodrigues-Júnior, Costa, Ximenes and Sougey2019 ; Elkana et al., Reference Elkana, Tal, Oren, Soffer and Ash2020 ; Kirkbride et al., Reference Kirkbride, Ferreira-Correia and Sibandze2022 ; Daniel et al., Reference Daniel, Agenagnew, Workicho and Abera2022). Although female sex showed a negative association with MoCA scores, this needs to be interpreted with caution as the sample comprised a disproportionate number of females. Females also had significantly lower levels of education, which may explain the lower MoCA scores. The effect of sex on the MoCA is not as clear in the literature, with some studies reporting significant differences in performance between males and females, whereas others do not (Lu et al., Reference Lu, Li, Li, Zhou, Wang, Zuo, Jia, Song and Jia2011; Robbins et al., Reference Robbins, Joska, Thomas, Stein, Linda, Mellins and Remien2013; Kaya et al., Reference Kaya, Aki, Can, Derle, Kibarolu and Barak2014; Santangelo et al., Reference Santangelo, Siciliano, Pedone, Vitale, Falco, Bisogno, Siano, Barone, Grossi, Santangelo and Trojano2015). There was also a significant negative correlation between age and total years of education, which may, at least to some degree, account for the correlation between age and lower MoCA total scores.

Limitations

This study had several limitations. First, while we used the RBANS, with adaptations, as our comparator screening tool for mild NCD, it has not been validated in the South African population. The importance of validating both the MoCA and RBANS in the population in which they are being administered cannot be overemphasized and is demonstrated by the poor specificity of the English version of the MoCA in this sample. Validation is the optimal way in which appropriate cut-off scores for positive and negative classification of cognitive impairment can be established. That said, to our knowledge, no screening tool for mild NCD has to date been validated in this population. Additionally, neither the MoCA nor the RBANS was culturally adapted for our population. While this does allow us to compare the psychometric performance with populations in other countries, it may also be a source of bias in the sample (Robbins et al., Reference Robbins, Joska, Thomas, Stein, Linda, Mellins and Remien2013). Second, the Afrikaans version of the MoCA was used for patients with Afrikaans as their first language; however, the Afrikaans version has not been standardized. Third, a few factors limit generalizability. Our population comprised individuals of mixed race (Colored ethnicity) and a disproportionate number of females (70.8%). Additionally, 79.5% of the sample completed high school, a number more than double that found nationally (37.3% in 2022) (Statistics South Africa, 2024). The mean age of participants was below 50 years, and older participants generally had lower educational levels compared to younger individuals. Consequently, the findings may not be generalizable to typical patients with cognitive impairment, which predominantly manifests after the age of 65.

Fourth, although we grouped participants according to years of education, we were unable to control for the quality of education. Given that many of the older participants were likely to have been educated during a period of South African history of structural inequality where there was a high degree of variation in the quality of education on the basis of race, this may have influenced performance on these measures. The effects of education on cognitive screening have been widely reported in the literature, to the extent that studies on the MoCA have, in the past, excluded illiterate individuals (Freitas et al., Reference Freitas, Simões, Alves and Santana2011 ) due to concerns that this would impact global scoring. Other studies have recommended changes to items (Yu et al., Reference Yu, Li and Huang2012 ; Hu et al., Reference Hu, Zhou, Hu, Huang, Wei, Qi, Wen and Xu2013 ) to accommodate for the lower level of education in their country compared to the level of education in the original Canadian MoCA validation sample (Nasreddine et al., Reference Nasreddine, Phillips, Bédirian, Charbonneau, Whitehead, Collin, Cummings and Chertkow2005 ). The wide range of education in our sample is likely a representation of the South African population (OECD, 2019), and as such, we followed the latter approach and identified items that participants performed poorly at. If these are also identified in other local studies, it may be prudent to remove or modify them.

Conclusion

To the best of our knowledge, this is the first study to directly evaluate and compare the MoCA and RBANS in a South African setting. While the MoCA, because of its brevity, may be a useful and time-saving screener for mild NCD in this population, our findings suggest that some modification is required for certain domains and items to improve the identification of mild NCD. Until such time that a culturally adapted version of the MoCA has been developed and validated for a population matching our sample, we suggest lowering the cut-off score of the MoCA from 26 to 25 in the English sample, and to 23 or 24 in the Afrikaans sample, in an effort to reduce the false positive detection rate of mild NCD. In the interim, hopefully our findings can contribute to using an informed approach when using and interpreting the MoCA in our varied and resource-constrained settings.

We recommend replication studies comparing the performance of the MoCA compared to the RBANS in other South African ethnic groups and languages to determine if this cut-off can be reproduced. Screening for mild NCD with the MoCA does not, however, replace a more comprehensive neurocognitive assessment. Nonetheless, this study paves the way for future studies of psychometric analysis of the MoCA that focus on scale validity (i.e., exploratory, and confirmatory factor analysis) and test–retest reliability. In addition, validating the MoCA against a gold standard comprehensive cognitive battery will be an important next step in our context.

Open peer review

To view the open peer review materials for this article, please visit http://doi.org/10.1017/gmh.2025.10050.

Author contribution

SSu: Conceptualisation, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – original draft, Writing - review & editing; EB: Conceptualisation, Data curation, Investigation, Methodolgy, Validation, Visualisation, Writing - original draft, Writing - review & editing; NB: Formal analysis, Writing - original draft; LvdH: Conceptualization, Data curation, Investigation, Methodology, Project administration, Validation, Visualization, Writing - review & editing; LA: Investigation, review & editing; SK: Investigation, review & editing; RE: Investigation, review & editing; JC: Conceptualization, Funding acquisition, Methodology, Supervision, Writing - review & editing; SSe: Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing - review & editing; All authors have read and approved the final version.

Financial support

Research reported in this publication was supported by the South African Medical Research Council (SAMRC) for the “Shared Roots” Flagship Project, Grant no. MRC-RFA-IFSP-01-2013/SHARED ROOTS” through funding received from the South African National Treasury under its Economic Competitiveness and Support Package.

SSu received post-doctoral support from the South African Research Chairs Initiative in PTSD funded by the Department of Science and Technology and the South African National Research Foundation (NRF), funding from the SAMRC through a Self-Initiated Research Grant, and funding from the NRF through the Competitive Programme for Rated Researchers (Grant Number SRUG2204123207).

LvdH was supported in part by the NRF (Grant Number 138430) and by the SAMRC under a Self-Initiated Research Grant.

EB was supported by the South African Medical Research Council Unit on Genomics of Brain Disorders.

SSe was supported by the South African Medical Research Council and was the recipient of the Shared Roots grant (MRC-RFA-IFSP-01-2013/SHARED ROOTS).

RE has received honoraria from AstraZeneca, Bristol-Myers Squibb, Janssen, Lilly, Lundbeck, Organon, Pfizer, Servier, Otsuka and Wyeth. He has also received research funding from Janssen, Lundbeck and AstraZeneca.

Funders have played no role in the study design, data collection, analysis, and interpretation and in writing the manuscript. Its’ contents are solely the responsibility of the authors and do not necessarily represent the official views of the South African MRC or NRF.

Competing interest

The authors declare none.

Ethical approval

This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval for the study was obtained from the Health Research Ethics Committee of the Faculty of Medicine and Health Sciences (FHMS), Stellenbosch University (SU) (N13/08/115), and all participants provided informed consent.

References

Alkhatib, A, Nnyanzi, LA, Mujuni, B, Amanya, G and Ibingira, C (2021) Preventing multimorbidity with lifestyle interventions in Sub-Saharan Africa: A new challenge for public health in low and middle-income countries. International Journal of Environmental Research and Public Health 18(23). https://doi.org/10.3390/IJERPH182312449.Google Scholar
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders. https://doi.org/10.1176/APPI.BOOKS.9780890425596.Google Scholar
Arch, A and Ferraro, FR (2021) Performance on the repeatable battery for the assessment of neuropsychological status in college students with mild traumatic brain injury. Applied Neuropsychology. Adult 28(2), 220229. https://doi.org/10.1080/23279095.2019.1626236.Google Scholar
Breijyeh, Z and Karaman, R (2020) Comprehensive review on Alzheimer’s disease: Causes and treatment. Molecules (Basel, Switzerland) 25(24). https://doi.org/10.3390/MOLECULES25245789.Google Scholar
Bucher, AL, Leonhard, C and Michael Bradley, J (2022) Use of the RBANS to Assess for HIV-Associated Neurocognitive Disorder. (accessed 28 January 2025).Google Scholar
Cassambai, S, Tetteh, J, Highton, P, Kunutsor, SK, Darko, DO, Jeffers, S, Ikhile, D, Agot, GN, Olenja, J, Njoroge, PK, Jessen, N, Abdala, R, Senior, L, Coleman, MA, Khunti, K, Godia, PM, Alfred, YE, Lamptey, R, Buabeng, KO, Damasceno, A and Seidu, SI (2024) Prevalence of Cardiometabolic Diseases in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. https://doi.org/10.2139/SSRN.5017937.Google Scholar
Cho, MH, Shin, DW, Chang, SA, Lee, JE, Jeong, SM, Kim, SH, Yun, JM and Son, K (2018) Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia. Scientific Reports 8(1). https://doi.org/10.1038/S41598-018-29974-7.Google Scholar
Conti, S, Bonazzi, S, Laiacona, M, Masina, M and Coralli, MV (2015) Montreal cognitive assessment (MoCA)-Italian version: Regression based norms and equivalent scores. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 36(2), 209214. https://doi.org/10.1007/S10072-014-1921-3.Google Scholar
Daniel, B, Agenagnew, L, Workicho, A and Abera, M (2022) Psychometric properties of the Montreal cognitive assessment (MoCA) to detect major neurocognitive disorder among older people in Ethiopia: A validation study. Neuropsychiatric Disease and Treatment 18, 17891798. https://doi.org/10.2147/NDT.S377430.Google Scholar
De La Torre, GG, Suárez-Llorens, A, Caballero, FJ, Ramallo, MA, Randolph, C, Lleó, A, Sala, I and Sánchez, B (2014) Norms and reliability for the Spanish version of the repeatable battery for the assessment of neuropsychological status (RBANS). Form A. Journal of Clinical and Experimental Neuropsychology 36(10), 10231030. https://doi.org/10.1080/13803395.2014.965664.Google Scholar
de Villiers, K (2021) Bridging the health inequality gap: An examination of South Africa’s social innovation in health landscape. Infectious Diseases of Poverty 10(1), 17. https://doi.org/10.1186/S40249-021-00804-9/METRICS.Google Scholar
Docrat, S, Besada, D, Cleary, S, Daviaud, E and Lund, C (2019) Mental health system costs, resources and constraints in South Africa: A national survey. Health Policy and Planning 34(9), 706719. https://doi.org/10.1093/HEAPOL/CZZ085.Google Scholar
Dolansky, MA, Hawkins, MAW, Schaefer, JT, Sattar, A, Gunstad, J, Redle, JD, Josephson, R, Moore, SM and Hughes, JW (2016) Association between poorer cognitive function and reduced objectively monitored medication adherence in patients with heart failure. Circulation. Heart Failure 9(12). https://doi.org/10.1161/CIRCHEARTFAILURE.116.002475.Google Scholar
Duff, K, Hobson, VL, Beglinger, LJ and O’Bryant, SE (2010) Diagnostic accuracy of the RBANS in mild cognitive impairment: Limitations on assessing milder impairments. Archives of Clinical Neuropsychology 25(5), 429441. https://doi.org/10.1093/ARCLIN/ACQ045.Google Scholar
Elkana, O, Tal, N, Oren, N, Soffer, S and Ash, EL (2020) Is the cutoff of the MoCA too high? Longitudinal data from highly educated older adults. Journal of Geriatric Psychiatry and Neurology 33(3), 155160. https://doi.org/10.1177/0891988719874121.Google Scholar
Faust, K, Nelson, BD, Sarapas, C and Pliskin, NH (2017) Depression and performance on the repeatable battery for the assessment of neuropsychological status. Applied Neuropsychology. Adult 24(4), 350356. https://doi.org/10.1080/23279095.2016.1185426.Google Scholar
Franzoi, MA, Agostinetto, E, Perachino, M, Del Mastro, L, de Azambuja, E, Vaz-Luis, I, Partridge, AH and Lambertini, M (2021) Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer. The Lancet. Oncology 22(7), e303e313. https://doi.org/10.1016/S1470-2045(20)30666-5.Google Scholar
Freitas, S, Simões, MR, Alves, L and Santana, I (2011) Montreal cognitive assessment (MoCA): Normative study for the Portuguese population. Journal of Clinical and Experimental Neuropsychology 33(9), 989996. https://doi.org/10.1080/13803395.2011.589374.Google Scholar
Geller, R and Slicer, K (2024) Montreal Cognitive Assessment (MoCA). Clinical Integration of Neuropsychological Test Results, 191204. https://doi.org/10.1201/9781003309604-29.Google Scholar
Greene, MC, Yangchen, T, Lehner, T, Sullivan, PF, Pato, CN, McIntosh, A, Walters, J, Gouveia, LC, Msefula, CL, Fumo, W, Sheikh, TL, Stockton, MA, Wainberg, ML and Weissman, MM (2021) The epidemiology of psychiatric disorders in Africa: A scoping review. The Lancet. Psychiatry 8(8), 717731. https://doi.org/10.1016/S2215-0366(21)00009-2.Google Scholar
Guilmette, TJ, Sweet, JJ, Hebben, N, Koltai, D, Mahone, EM, Spiegler, BJ, Stucky, K and Westerveld, M (2020) American Academy of Clinical Neuropsychology consensus conference statement on uniform labeling of performance test scores. The Clinical Neuropsychologist 34(3), 437453. https://doi.org/10.1080/13854046.2020.1722244.Google Scholar
Hagi, K, Nosaka, T, Dickinson, D, Lindenmayer, JP, Lee, J, Friedman, J, Boyer, L, Han, M, Abdul-Rashid, NA and Correll, CU (2021) Association between cardiovascular risk factors and cognitive impairment in people with schizophrenia: A systematic review and meta-analysis. JAMA Psychiatry 78(5), 510518. https://doi.org/10.1001/JAMAPSYCHIATRY.2021.0015.Google Scholar
Hakkers, CS, Beunders, AJM, Ensing, MHM, Barth, RE, Boelema, S, Devillé, WLJ, Tempelman, HA, Coutinho, RA, Hoepelman, AIM, Arends, JE and van Zandvoort, MJE (2018) The Montreal cognitive assessment-basic (MoCA-B) is not a reliable screening tool for cognitive decline in HIV patients receiving combination antiretroviral therapy in rural South Africa. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases 67, 3640. https://doi.org/10.1016/J.IJID.2017.11.024.Google Scholar
Hernandez-Ruiz, V, Letenneur, L, Fülöp, T, Helmer, C, Roubaud-Baudron, C, Avila-Funes, JA and Amieva, H (2022) Infectious diseases and cognition: Do we have to worry? Neurological Sciences 43(11), 6215. https://doi.org/10.1007/S10072-022-06280-9.Google Scholar
Hill, NL, McDermott, C, Mogle, J, Munoz, E, Depasquale, N, Wion, R and Whitaker, E (2017) Subjective cognitive impairment and quality of life: A systematic review. International Psychogeriatrics 29(12), 19651977. https://doi.org/10.1017/S1041610217001636.Google Scholar
Hu, J-b, Zhou, W-h, Hu, S-h, Huang, M-l, Wei, N, Qi, H-l, Wen, J-w and Xu, Y (2013) Cross-cultural difference and validation of the Chinese version of Montreal cognitive assessment in older adults residing in Eastern China: Preliminary findings. Archives of Gerontology and Geriatrics 56(1), 3843. https://doi.org/10.1016/J.ARCHGER.2012.05.008.Google Scholar
Ikanga, J, Patrick, SD, Schwinne, M, Patel, SS, Epenge, E, Gikelekele, G, Tshengele, N, Kavugho, I, Mampunza, S, Yarasheski, KE, Teunissen, CE, Stringer, A, Levey, A, Rojas, JC, Chan, B, Lario Lago, A, Kramer, JH, Boxer, AL, Jeromin, A, Alonso, A and Spencer, RJ (2024) Sensitivity of the African neuropsychology battery memory subtests and learning slopes in discriminating APOE 4 and amyloid pathology in adult individuals in the Democratic Republic of Congo. Frontiers in Neurology 15, 1320727. https://doi.org/10.3389/FNEUR.2024.1320727/BIBTEX.Google Scholar
Karantzoulis, S, Novitski, J, Gold, M and Randolph, C (2013) The repeatable battery for the assessment of neuropsychological status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer’s disease. Archives of Clinical Neuropsychology 28(8), 837844. https://doi.org/10.1093/ARCLIN/ACT057.Google Scholar
Kaya, Y, Aki, OE, Can, UA, Derle, E, Kibarolu, S and Barak, A (2014) Validation of Montreal cognitive assessment and discriminant power of Montreal cognitive assessment subtests in patients with mild cognitive impairment and Alzheimer dementia in Turkish population. Journal of Geriatric Psychiatry and Neurology 27(2), 103109. https://doi.org/10.1177/0891988714522701.Google Scholar
Kirkbride, E, Ferreira-Correia, A and Sibandze, M (2022) Montreal cognitive assessment: Exploring the impact of demographic variables, internal consistency reliability and discriminant validity in a South African sample. African Journal of Psychological Assessment 4. https://doi.org/10.4102/AJOPA.V4I0.73.Google Scholar
Knight, MJ, Mills, NT and Baune, BT (2019) Contemporary methods of improving cognitive dysfunction in clinical depression. Expert Review of Neurotherapeutics 19(5), 431443. https://doi.org/10.1080/14737175.2019.1610395.Google Scholar
Lau, HY, Lin, YH, Lin, KC, Li, YC, Yao, G, Lin, CY and Wu, YH (2024) Reliability of the Montreal cognitive assessment in people with stroke. International Journal of Rehabilitation Research. Internationale Zeitschrift Fur Rehabilitationsforschung. Revue Internationale de Recherches de Readaptation 47(1), 4651. https://doi.org/10.1097/MRR.0000000000000612.Google Scholar
Lu, Y, Fülöp, T, Gwee, X, Lee, TS, Lim, WS, Chong, MS, Yap, PLK, Yap, KB, Pan, F and Ng, TP (2022) Cardiometabolic and vascular disease factors and mild cognitive impairment and dementia. Gerontology 68(9). https://doi.org/10.1159/000521547.Google Scholar
Lu, J, Li, D, Li, F, Zhou, A, Wang, F, Zuo, X, Jia, XF, Song, H and Jia, J (2011) Montreal cognitive assessment in detecting cognitive impairment in Chinese elderly individuals: A population-based study. Journal of Geriatric Psychiatry and Neurology 24(4), 184190. https://doi.org/10.1177/0891988711422528.Google Scholar
Malan, L, Zandberg, L, Visser, MV, Wicks, M, Kruger, HS and Faber, M (2024) Biochemical assessment of the nutritional status of infants, children and adolescents in South Africa (1997–2022): A systematic review. Public Health Nutrition 27(1), e210. https://doi.org/10.1017/S136898002400137X.Google Scholar
Malek-Ahmadi, M, Powell, JJ, Belden, CM, Oconnor, K, Evans, L, Coon, DW and Nieri, W (2015) Age- and education-adjusted normative data for the Montreal cognitive assessment (MoCA) in older adults age 70-99. Neuropsychology, Development, and Cognition Section B, Aging, Neuropsychology and Cognition 22(6), 755761. https://doi.org/10.1080/13825585.2015.1041449.Google Scholar
Martin Prince, A, Wimo, A, Guerchet, M, Gemma-Claire Ali, M, Y-T, Wu, Prina, M, Yee Chan, K and Xia, Z (2015, September 21) World Alzheimer Report 2015: The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends.Google Scholar
Masika, GM, Yu, DSF and Li, PWC (2021) Accuracy of the Montreal cognitive assessment in detecting mild cognitive impairment and dementia in the rural African population. Archives of Clinical Neuropsychology 36(3), 371380. https://doi.org/10.1093/ARCLIN/ACZ086.Google Scholar
Memõria, CM, Yassuda, MS, Nakano, EY and Forlenza, OV (2013) Brief screening for mild cognitive impairment: Validation of the Brazilian version of the Montreal cognitive assessment. International Journal of Geriatric Psychiatry 28(1), 3440. https://doi.org/10.1002/GPS.3787.Google Scholar
Monyeki, KD, Mkhatshwa, TN, Thulare, LP, Kemper, HCG, Kengne, AP and Moselakgomo, VK (2023) Development of cardiometabolic risk factors among rural population of Lephalale, South Africa: A systematic review on Elliras longitudinal study. African Journal for Physical Activity and Health Sciences 29(1), 5669. https://www.ajol.info/index.php/ajpherd/article/view/260775 (accessed 23 December 2024).Google Scholar
Narazaki, K, Nofuji, Y, Honda, T, Matsuo, E, Yonemoto, K and Kumagai, S (2012) Normative data for the Montreal cognitive assessment in a Japanese community-dwelling older population. Neuroepidemiology 40(1), 2329. https://doi.org/10.1159/000339753.Google Scholar
Nasreddine, ZS, Phillips, NA, Bédirian, V, Charbonneau, S, Whitehead, V, Collin, I, Cummings, JL and Chertkow, H (2005) The Montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society 53(4), 695699. https://doi.org/10.1111/J.1532-5415.2005.53221.X.Google Scholar
Nezhadmoghadam, F, Martinez-Torteya, A, Treviño, V, Martínez, E, Santos, A, Tamez-Peña, J and Alzheimer’s Disease Neuroimaging Initiative (2021) Robust discovery of mild cognitive impairment subtypes and their risk of Alzheimer’s disease conversion using unsupervised machine learning and Gaussian mixture modeling. Current Alzheimer Research 18(7), 595606. https://doi.org/10.2174/1567205018666210831145825.Google Scholar
OECD (2019) Development Co-operation Report 2019.Google Scholar
Pandya, SP (2020) Older adults who meditate regularly perform better on neuropsychological functioning and visual working memory tests: A three-month waitlist control design study with a cohort of seniors in assisted living facilities. Experimental Aging Research 46(3), 214235. https://doi.org/10.1080/0361073X.2020.1743951.Google Scholar
Paul, R, Lane, EM, Tate, DF, Heaps, J, Romo, DM, Akbudak, E, Niehoff, J and Conturo, TE (2011) Neuroimaging signatures and cognitive correlates of the Montreal cognitive assessment screen in a nonclinical elderly sample. Archives of Clinical Neuropsychology 26(5), 454460. https://doi.org/10.1093/ARCLIN/ACR017.Google Scholar
Pinto, TCC, Machado, L, Bulgacov, TM, Rodrigues-Júnior, AL, Costa, MLG, Ximenes, RCC and Sougey, EB (2019) Is the Montreal cognitive assessment (MoCA) screening superior to the Mini-mental state examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) in the elderly? International Psychogeriatrics 31(4), 491504. https://doi.org/10.1017/S1041610218001370.Google Scholar
Rademeyer, M and Joubert, P (2016) A comparison between the Mini-mental state examination and the Montreal cognitive assessment test in schizophrenia. South African Journal of Psychiatry 22(1), 5. https://doi.org/10.4102/SAJPSYCHIATRY.V22I1.890.Google Scholar
Randolph, C, Tierney, MC, Mohr, E and Chase, TN (1998) The repeatable battery for the assessment of neuropsychological status (RBANS): Preliminary clinical validity. Journal of Clinical and Experimental Neuropsychology 20(3), 310319. https://doi.org/10.1076/JCEN.20.3.310.823.Google Scholar
Rasmussen, J and Langerman, H (2019) Alzheimer’s disease – Why we need early diagnosis. Degenerative Neurological and Neuromuscular Disease 9, 123130. https://doi.org/10.2147/DNND.S228939.Google Scholar
Robbins, RN, Joska, JA, Thomas, KGF, Stein, DJ, Linda, T, Mellins, CA and Remien, RH (2013) Exploring the utility of the Montreal cognitive assessment to detect HIV-associated neurocognitive disorder: The challenge and need for culturally valid screening tests in South Africa. The Clinical Neuropsychologist 27(3), 437. https://doi.org/10.1080/13854046.2012.759627.Google Scholar
Sabbagh, MN, Boada, M, Borson, S, Chilukuri, M, Dubois, B, Ingram, J, Iwata, A, Porsteinsson, AP, Possin, KL, Rabinovici, GD, Vellas, B, Chao, S, Vergallo, A and Hampel, H (2020) Early detection of mild cognitive impairment (MCI) in primary care. Journal of Prevention of Alzheimer’s Disease 7(3), 165170. https://doi.org/10.14283/JPAD.2020.21/METRICS.Google Scholar
Sachs, G, Berg, A, Jagsch, R, Lenz, G and Erfurth, A (2020) Predictors of functional outcome in patients with bipolar disorder: Effects of cognitive psychoeducational group therapy after 12 months. Frontiers in Psychiatry 11. https://doi.org/10.3389/FPSYT.2020.530026.Google Scholar
Salzman, T, Sarquis-Adamson, Y, Son, S, Montero-Odasso, M and Fraser, S (2022) Associations of multidomain interventions with improvements in cognition in mild cognitive impairment: A systematic review and meta-analysis. JAMA Network Open 5(5), e226744e226744. https://doi.org/10.1001/JAMANETWORKOPEN.2022.6744.Google Scholar
Santangelo, G, Siciliano, M, Pedone, R, Vitale, C, Falco, F, Bisogno, R, Siano, P, Barone, P, Grossi, D, Santangelo, F and Trojano, L (2015) Normative data for the Montreal cognitive assessment in an Italian population sample. Neurological Sciences: Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 36(4), 585591. https://doi.org/10.1007/S10072-014-1995-Y.Google Scholar
Savedra, MMG, Rosenberg, P, Macedo, AL and Macedo, AL (2021) Language and ethnicity among coloured students in Cape Town. Gragoatá 26(54), 380404. https://doi.org/10.22409/GRAGOATA.V26I54.46355.Google Scholar
Shaughnessy, MF, Rucker, L and Sanchez, AA (2019) A reflective review of the RBANS. Arcjournals Org ARC Journal of Psychiatry 4(1), 39. www.arcjournals.org (accessed 21 February 2025).Google Scholar
Sheehan, D V., Lecrubier, Y, Sheehan, KH, Amorim, P, Janavas, J, Weiller, E, Hergueta, TBR and Dunbar, GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): The Development and Validation of a Structured Diagnostic Psychiatric Interview for DSM-IV and ICD-10 – PubMed. https://pubmed.ncbi.nlm.nih.gov/9881538/ (accessed 21 February 2025).Google Scholar
Shisana, O, Stein, DJ, Zungu, NP and Wolvaardt, G (2024) The rationale for South Africa to prioritise mental health care as a critical aspect of overall health care. Comprehensive Psychiatry 130, 152458. https://doi.org/10.1016/J.COMPPSYCH.2024.152458.Google Scholar
Statistics South Africa (2024) Trends in Youth Educational Attainment. Statistics South Africa. https://www.statssa.gov.za/?p=17323 (accessed 1 March 2025).Google Scholar
Suliman, S, van den Heuvel, LL, Kilian, S, Bröcker, E, Asmal, L, Emsley, R and Seedat, S (2021) Cognitive insight is associated with perceived body weight in overweight and obese adults. BMC Public Health 21(1). https://doi.org/10.1186/S12889-021-10559-5.Google Scholar
Thaler, NS, Hill, BD, Duff, K, Mold, J and Scott, JG (2015) Repeatable battery for the assessment of neuropsychological status (RBANS) intraindividual variability in older adults: Associations with disease and mortality. Journal of Clinical and Experimental Neuropsychology 37(6), 622629. https://doi.org/10.1080/13803395.2015.1039962.Google Scholar
Thungana, Y (2022) An Evaluation of the Psychometric Properties of the Montreal Cognitive Assessment Tool when Administered in a Memory Clinic At Groote Schuur Hospital, Cape Town, South Africa. http://hdl.handle.net/11427/37340 (accessed 23 December 2024).Google Scholar
van den Heuvel, LL, Stalder, T, du Plessis, S, Suliman, S, Kirschbaum, C and Seedat, S (2020) Hair cortisol levels in posttraumatic stress disorder and metabolic syndrome. Stress (Amsterdam, Netherlands) 23(5), 577589. https://doi.org/10.1080/10253890.2020.1724949.Google Scholar
Van Wijk, CH, Meintjes, WAJ, Muller, CJB, Van Wijk, C, Wijk, V, Meintjes, CH and Muller, (2024) Montreal cognitive assessment test: Psychometric analysis of a South African workplace sample. African Journal of Psychological Assessment 6, 12. https://doi.org/10.4102/AJOPA.V6I0.151.Google Scholar
Varghese, S, Frey, BN, Schneider, MA, Kapczinski, F and de Azevedo Cardoso, T (2022) Functional and cognitive impairment in the first episode of depression: A systematic review. Acta Psychiatrica Scandinavica 145(2), 156185. https://doi.org/10.1111/ACPS.13385.Google Scholar
Weber, CJ, Randolph, C and Negash, S (2019) P1-473: Cross-cultural applicability of the repeatable battery for the assessment of neuropsychological status (RBANS) in cognitively normal subjects. Alzheimer’s & Dementia 15(7S_Part_8). https://doi.org/10.1016/J.JALZ.2019.06.1078.Google Scholar
Wolfova, K, Kucera, M and Cermakova, P (2021) Risk and protective factors of neurocognitive disorders in older adults in central and Eastern Europe: A systematic review of population-based studies. PLoS One 16(11), e0260549. https://doi.org/10.1371/JOURNAL.PONE.0260549.Google Scholar
Wong, A, Law, LSN, Liu, W, Wang, Z, Lo, ESK, Lau, A, Wong, LKS and Mok, VCT (2015) Montreal cognitive assessment: One cutoff never fits all. Stroke 46(12), 35473550. https://doi.org/10.1161/STROKEAHA.115.011226.Google Scholar
World Health Organization (WHO) (2024) Noncommunicable diseases. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases (accessed 1 March 2025).Google Scholar
Wu, C, Yu, R, Li, Q, Chen, J and Wang, W (2023) Exploring the impact of cognitive impairments on treatment compliance and quality of life in patients with continuous ambulatory peritoneal dialysis (CAPD). Medicine 102(43), E35813. https://doi.org/10.1097/MD.0000000000035813.Google Scholar
Yang, C, Garrett-Mayer, E, Schneider, JS, Gollomp, SM and Tilley, BC (2009) Repeatable battery for assessment of neuropsychological status in early Parkinson’s disease. Movement Disorders: Official Journal of the Movement Disorder Society 24(10), 14531460. https://doi.org/10.1002/MDS.22552.Google Scholar
Yu, J, Li, J and Huang, X (2012) The Beijing version of the Montreal cognitive assessment as a brief screening tool for mild cognitive impairment: A community-based study. BMC Psychiatry 12(1), 18. https://doi.org/10.1186/1471-244X-12-156.Google Scholar
Zhang, C, Luo, J, Yuan, C and Ding, D (2020) Vitamin B12, B6, or folate and cognitive function in community-dwelling older adults: A systematic review and meta-analysis. Journal of Alzheimer’s Disease: JAD 77(2), 781794. https://doi.org/10.3233/JAD-200534.Google Scholar
Zhang, YR, Xu, W, Zhang, W, Wang, HF, Ou, YN, Qu, Y, Shen, XN, Chen, SD, Wu, KM, Zhao, QH, Zhang, HN, Sun, L, Dong, Q, Tan, L, Feng, L, Zhang, C, Evangelou, E, Smith, AD and Yu, JT (2022) Modifiable risk factors for incident dementia and cognitive impairment: An umbrella review of evidence. Journal of Affective Disorders 314, 160167. https://doi.org/10.1016/J.JAD.2022.07.008.Google Scholar
Zhou, HH, Yu, Z, Luo, L, Xie, F, Wang, Y and Wan, Z (2021) The effect of hormone replacement therapy on cognitive function in healthy postmenopausal women: A meta-analysis of 23 randomized controlled trials. Psychogeriatrics: The Official Journal of the Japanese Psychogeriatric Society 21(6), 926938. https://doi.org/10.1111/PSYG.12768.Google Scholar
Zhuang, L, Yang, Y and Gao, J (2021) Cognitive assessment tools for mild cognitive impairment screening. Journal of Neurology 268(5), 16151622. https://doi.org/10.1007/S00415-019-09506-7.Google Scholar
Figure 0

Table 1. Participant characteristics stratified by language

Figure 1

Table 2. MoCA item scores

Figure 2

Figure 1. (a) Bland–Altman Plot – English. (b) Bland–Altman Plot – Afrikaans.

Figure 3

Figure 2. (a) ROC Curve: MoCA compared to RBANS – English. (b) ROC Curve: MoCA compared to RBANS – Afrikaans.

Figure 4

Table 3. Summary of different MoCA cut-off scores predicting MCI on the RBANS